CORRECTION: IM Cannabis Q2 EPS $(0.19) Misses $(0.07) Estimate, Sales $9.83M Miss $13.44M Estimate
Portfolio Pulse from Happy Mohamed
IM Cannabis (NASDAQ:IMCC) reported Q2 losses of $(0.19) per share, missing the analyst consensus estimate of $(0.07) by 171.43%. The company also reported quarterly sales of $9.83 million, missing the analyst consensus estimate of $13.44 million by 26.85%. This represents a 92.08% increase in losses and a 47.33% decrease in sales compared to the same period last year.
August 14, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IM Cannabis reported higher than expected losses and lower than expected sales for Q2, which could negatively impact the stock price.
IM Cannabis reported a significant miss on both earnings and sales for Q2. This underperformance is likely to negatively impact investor sentiment and could lead to a decrease in the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100